Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience

Subcutaneous Implantable Cardioverter‐Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Transatlantic Experience

Background Despite growing use of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD), its clinical role in arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) patients remains undefined. We aim to elucidate the cardiac phenotype, implant characteristics, and long‐term eff...

Full description

Bibliographic Details
Main Authors:	Gabriela M. Orgeron, Aditya Bhonsale, Federico Migliore, Cynthia A. James, Crystal Tichnell, Brittney Murray, Emanuele Bertaglia, Julia Cadrin‐Tourigny, Pietro De Franceschi, Jane Crosson, Harikrishna Tandri, Domenico Corrado, Hugh Calkins
Format:	Article
Language:	English
Published:	Wiley 2018-11-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	arrhythmogenic right ventricular cardiomyopathy implanted cardioverter defibrillator long‐term follow‐up ventricular tachycardia
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.118.008782

Similar Items

Implantable Cardioverter‐Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications
by: Gabriela M. Orgeron, et al.
Published: (2017-11-01)

Implantable cardioverter – defibrillators in patients with suboptimal neurological status
by: Konstantinos A. Gatzoulis, et al.
Published: (2020-09-01)

Incidence, Predictors and Clinical Impact of Ventricular Electrical Storm in Arrhythmogenic Cardiomyopathy Patients with an Implantable Cardioverter–Defibrillator: A Single-Center Report with Medium-Term Follow-Up
by: Zhai L, et al.
Published: (2021-12-01)

Efficacy of Additional Amiodarone Therapy in Patients with an Implantable Cardioverter-Defibrillator
by: Naomichi Matsumoto, MD, et al.
Published: (2010-01-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

AV Nodal Reentrant Tachycardia Causing Inappropriate ICD Shocks In A Patient With Arrhythmogenic RV Dysplasia
by: Subbareddy Vanga, et al.
Published: (2009-01-01)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
by: Jun Kishihara, MD, et al.
Published: (2016-02-01)

Exercise: A Risky Subject in Arrhythmogenic Cardiomyopathy
by: Marina Cerrone
Published: (2018-06-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
by: Fadi Mansour, MD, et al.
Published: (2020-02-01)

Epicardial cardioverter defibrillator implantation due to post-fontan ventricular tachycardia
by: Nikolaos A Papakonstantinou, et al.
Published: (2020-01-01)

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)

A Tragic Case of Wearable Cardioverter-Defibrillator Failure
by: Ariel Vinas, MD, et al.
Published: (2021-02-01)

Ventricular tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy: How to Manage?
by: diah ivana, et al.
Published: (2022-05-01)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
by: Yoshimori An, MD, et al.
Published: (2017-02-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

Arrhythmogenic Right Ventricular Cardiomyopathy - what do we know? A review of current knowledge state
by: Jan Radwański, et al.
Published: (2023-08-01)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
by: Fabrizio Guarracini, et al.
Published: (2023-07-01)

TACTICS OF PRENATAL CARE OF A YOUNG PATIENT WITH INHERITED LONG QT SYNDROME AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R B Tatarsky, et al.
Published: (2018-12-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Management of patients following implantable cardioverter‐defibrillator therapy—The importance of a multifaceted approach
by: Karshana Selvarajah, et al.
Published: (2025-02-01)

The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
by: Özge Çakmak Karaaslan, et al.
Published: (2023-01-01)

Right Ventricular Strain Predicts Structural Disease Progression in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
by: Nitin Malik, et al.
Published: (2020-04-01)

Mid-term follow-up of patients with Brugada syndrome following a cardioverter defibrillator implantation: A single center experience
by: Jorat MV, et al.
Published: (2007-01-01)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
by: David Duncker, et al.
Published: (2017-01-01)

Ineffective implantable cardioverter-defibrillator shocks among patients on continuous left ventricular assist device support: Clinical characteristics and management
by: Malik Shehadeh, MD, et al.
Published: (2020-12-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

Successful repositioning of the subcutaneous implantable cardioverter‐defibrillator lead to avoid inappropriate shock
by: Hiroshi Fukunaga, et al.
Published: (2023-02-01)

Low QRS voltage and atrial fibrillation precluding implantation of a subcutaneous implantable cardioverterdefibrillator in a patient with arrhythmogenic cardiomyopathy
by: Peter C. Kahr, et al.
Published: (2017-12-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience
by: Paul J. Scheel III, et al.
Published: (2022-04-01)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
by: Matthew F. Yuyun, MD, MPhil, PhD, et al.
Published: (2020-05-01)

Implantable Cardioverter Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices: Utilization Patterns, Related Procedures, and Complications
by: Paulino A. Alvarez, et al.
Published: (2019-07-01)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
by: Xuerong Sun, et al.
Published: (2021-09-01)

Implantable cardioverter defibrillators in the prevention of sudden cardiac death
by: L A Bockeria, et al.
Published: (2017-12-01)

Ventricular Tachycardia Precipitated by Short-long-short Sequence in a Patient with Implantable-cardioverter Defibrillator
by: Diego Chemello, MD, et al.
Published: (2012-01-01)

Prognostic value of noninvasive programmed stimulation in primary prevention implantable cardioverter‐defibrillator recipients
by: Piotr Futyma, et al.
Published: (2024-06-01)

A classic case of arrhythmogenic right ventricular cardiomyopathy (ARVC) and literature review
by: Htun Latt, et al.
Published: (2017-04-01)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
by: Thienel M, et al.
Published: (2022-11-01)